Alpha Cognition Inc. (NASDAQ:ACOG) Short Interest Down 32.1% in February

Alpha Cognition Inc. (NASDAQ:ACOG) was the target of a significant drop in short interest in the month of February. As of February 13th, there was short interest totaling 228,500 shares, a drop of 32.1% from the January 29th total of 336,614 shares. Based on an average daily volume of 85,433 shares, the days-to-cover ratio is presently 2.7 days. Approximately 1.2% of the company’s stock are sold short. Approximately 1.2% of the company’s stock are sold short. Based on an average daily volume of 85,433 shares, the days-to-cover ratio is presently 2.7 days.

Alpha Cognition Stock Performance

Shares of NASDAQ:ACOG opened at $6.00 on Friday. Alpha Cognition has a 52 week low of $3.75 and a 52 week high of $11.54. The company’s 50 day moving average is $5.78 and its two-hundred day moving average is $6.63. The company has a market cap of $130.44 million, a PE ratio of -4.38 and a beta of 2.60.

Wall Street Analyst Weigh In

Several equities analysts have commented on the stock. Wall Street Zen upgraded shares of Alpha Cognition from a “sell” rating to a “hold” rating in a research note on Saturday, November 15th. HC Wainwright reiterated a “buy” rating and issued a $18.00 target price on shares of Alpha Cognition in a report on Friday, December 19th. One analyst has rated the stock with a Buy rating, According to MarketBeat, the company currently has an average rating of “Buy” and an average target price of $18.00.

Institutional Investors Weigh In On Alpha Cognition

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Opaleye Management Inc. lifted its holdings in shares of Alpha Cognition by 1,698.5% in the 4th quarter. Opaleye Management Inc. now owns 2,070,784 shares of the company’s stock valued at $13,460,000 after purchasing an additional 1,955,642 shares during the last quarter. AWM Investment Company Inc. lifted its stake in shares of Alpha Cognition by 52.6% in the 4th quarter. AWM Investment Company Inc. now owns 1,672,168 shares of the company’s stock worth $10,869,000 after acquiring an additional 576,516 shares during the period. Alyeska Investment Group L.P. purchased a new stake in Alpha Cognition in the 4th quarter valued at approximately $2,372,000. Cable Car Capital LP grew its holdings in Alpha Cognition by 68.8% during the second quarter. Cable Car Capital LP now owns 869,002 shares of the company’s stock worth $8,108,000 after acquiring an additional 354,278 shares during the period. Finally, Sphera Funds Management LTD. grew its stake in shares of Alpha Cognition by 67.6% during the 4th quarter. Sphera Funds Management LTD. now owns 567,616 shares of the company’s stock worth $3,690,000 after purchasing an additional 228,864 shares during the period.

Alpha Cognition Company Profile

Alpha Cognition, Inc is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer’s Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.